Genome-scale CRISPR screens identify host factors that promote human coronavirus infection (Q112052445)

2

0 references

Moritz Schaefer

3

0 references

Abderrahmane Tagmount

4

0 references

Max Russo

5

0 references

Amin Sobh

6

0 references

Roya Rafiee

7

0 references

Chris D Vulpe

8

0 references

Stephanie M Karst

9

0 references

Michael H Norris

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

10

0 references

language of work or name

English

0 references

publication date

27 January 2022

0 references

published in

Genome Medicine

0 references

volume

14

0 references

page(s)

10

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

The molecular virology of Coronaviruses

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Added value of an oropharyngeal swab in detection of viruses in children hospitalized with lower respiratory tract infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Opposing activities of IFITM proteins in SARS-CoV-2 infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A Crisp(r) New Perspective on SARS-CoV-2 Biology

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

DrugBank 5.0: a major update to the DrugBank database for 2018.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Rotavirus Induces Formation of Remodeled Stress Granules and P Bodies and Their Sequestration in Viroplasms To Promote Progeny Virus Production.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Overexpression of C16orf74 is involved in aggressive pancreatic cancers

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Role of heparan sulfate in the Zika virus entry, replication, and cell death

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

P bodies, stress granules, and viral life cycles

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Genome-scale CRISPR-Cas9 knockout screening in human cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Molecular identification and functional characterization of the human colonic thiamine pyrophosphate transporter

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

PAVOOC: designing CRISPR sgRNAs using 3D protein structures and functional domain annotations

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A genome-wide CRISPR-Cas9 screen reveals the requirement of host cell sulfation for Schmallenberg virus infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

The future of antivirals: broad-spectrum inhibitors

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

HSP90: a promising broad-spectrum antiviral drug target.

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

A Mini-Review on Cell Cycle Regulation of Coronavirus Infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Identification of antiviral antihistamines for COVID-19 repurposing

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Defending Antiviral Cationic Amphiphilic Drugs That May Cause Drug-Induced Phospholipidosis

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

VISPR-online: a web-based interactive tool to visualize CRISPR screening experiments

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

17 May 2022

1 reference

https://api.crossref.org/works/10.1186/S13073-022-01013-1